Nattokinase is a fibrinolytic enzyme, meaning it helps break down blood clots, and taking it safely comes down to a few practical decisions: choosing the right dose (measured in fibrinolytic units, or FU), picking a formulation that survives your stomach acid, and knowing which medications and medical conditions make it genuinely dangerous. Most clinical trials have used doses between 2,000 and 10,800 FU per day, and systematic reviews of randomized controlled trials have found no notable adverse events at those levels. That safety record is reassuring, but it comes with serious caveats for anyone on blood-thinning drugs or facing surgery.
What Nattokinase Actually Does
Nattokinase is a protein produced by the bacterium Bacillus subtilis during the fermentation of soybeans into natto, a traditional Japanese food with a sticky, stringy texture that many Westerners find challenging.1MDPI / International Journal of Molecular Sciences. Nattokinase: An Oral Antithrombotic Agent for the Prevention of Cardiovascular Disease The enzyme has been used in Japanese diets for centuries, but Western interest in it as a supplement is relatively recent and driven primarily by its ability to dissolve fibrin, the protein mesh that forms the structural backbone of blood clots.
Beyond directly breaking down fibrin, nattokinase also appears to stimulate your body’s own clot-dissolving machinery. Laboratory research found that nattokinase culture solutions prompted human vascular endothelial cells to release tissue plasminogen activator (tPA), a natural clot-dissolving substance, at levels roughly five times higher than the control. In certain cell lines, that boost climbed as high as 20-fold.2Pathophysiology of Haemostasis and Thrombosis. Nattokinase-Promoted Tissue Plasminogen Activator Release from Human Cells So the enzyme works on two fronts: it chews through existing fibrin directly and it nudges your cells to ramp up their own clot-clearing activity. This dual mechanism is why researchers have been interested in nattokinase for cardiovascular health, but it also explains why combining it with pharmaceutical blood thinners can be risky.
How Much to Take
Nattokinase potency is measured in fibrinolytic units (FU), sometimes also labeled as fibrin units on supplement bottles. You will occasionally see an older unit called “fibrin degradation units” (FDU) on certain products. One FU is generally equivalent to one FDU, so if a label reads 2,000 FDU, that is the same as 2,000 FU. The Japan Nattokinase Association has recommended a minimum daily intake of 2,000 FU for cardiovascular support, and most clinical trials have used doses in the range of 2,000 to 10,800 FU per day.
An important finding from a large clinical study with over 1,000 participants showed that a dose of 3,600 FU per day was not effective at lowering lipid levels or suppressing atherosclerosis after 12 months of use. Lipid levels, carotid artery wall thickness, and plaque size did not meaningfully change at that dose.3PubMed Central. Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants This suggests that if your goal is specifically to manage cholesterol or arterial plaque, the lower end of the dosing range may not do much. Higher doses, around 6,000 to 10,800 FU daily, have shown more promising results in other trials, though the optimal dose has not been definitively nailed down.
A separate 26-week trial found that nattokinase reduced carotid plaque size by about 37%, compared to roughly 12% in a statin comparison group, alongside reductions in total cholesterol, LDL cholesterol, and triglycerides, and a notable increase in HDL cholesterol.4PubMed Central. A clinical study on the effect of nattokinase on carotid artery atherosclerosis and hyperlipidaemia That trial used a higher dose, which aligns with the observation from the larger study that 3,600 FU simply was not enough to move the needle on plaque.
If you are new to nattokinase and not taking any blood-thinning medications, a reasonable approach is to start at 2,000 FU daily and see how you tolerate it before increasing. Many supplement capsules come in 2,000 FU servings, making this straightforward. Just keep in mind that the cardiovascular benefits observed in research generally came from higher doses, so 2,000 FU may be a good starting floor but probably is not the ceiling for effect.
Timing and Absorption
There is no single clinical trial that definitively proves one timing strategy is superior to another for nattokinase. That said, the enzyme is a protein, which means your stomach’s acidic environment and digestive enzymes can partially break it down before it ever reaches the small intestine where absorption occurs. Research has confirmed that nattokinase is “intolerant to gastrointestinal conditions and is easily digested and degraded into polypeptides, oligopeptides, and amino acids” in the stomach.5PubMed Central. Virtual screening, activity evaluation, and stability of pancreatic lipase inhibitors in the gastrointestinal degradation of nattokinase This is the single biggest practical challenge with oral nattokinase.
Most practitioners and supplement manufacturers recommend taking nattokinase on an empty stomach, typically first thing in the morning or at least 30 minutes before a meal. The logic is that an empty stomach produces less gastric acid and fewer digestive enzymes than a stomach actively processing food, giving the enzyme a better chance of passing through to the intestine intact. Some people split their daily dose and take half in the morning and half before bed, which also spaces out the fibrinolytic activity throughout the day.
Taking nattokinase with a large, high-protein meal is probably the worst timing choice, because your stomach will be flooded with pepsin and hydrochloric acid meant to break down dietary protein, and nattokinase is a protein. It will get caught in the crossfire.
Why Formulation Matters More Than You Might Think
Because nattokinase is so vulnerable to stomach acid, the formulation of the supplement you buy can genuinely affect whether the enzyme reaches your bloodstream in active form or gets destroyed along the way. Enteric-coated tablets and capsules are designed to resist dissolving in the acidic environment of the stomach and instead release their contents in the more alkaline small intestine.
Laboratory research on compression-coated nattokinase tablets confirmed that this kind of coating protected the enzyme from gastric juice and allowed controlled release into the intestine.6Drug Development and Industrial Pharmacy. Stabilization and Target Delivery of Nattokinase Using Compression Coating A separate study explored self-emulsifying delivery systems and found they also effectively shielded nattokinase activity in a simulated gastric environment.7Asian Journal of Pharmaceutical Sciences. Preparation and evaluation of nattokinase-loaded self-double-emulsifying drug delivery system These findings reinforce a practical point: a bare, uncoated nattokinase powder dumped into a gelatin capsule is likely to lose a significant portion of its activity before it can do anything useful.
When shopping for nattokinase, look for products that specifically mention enteric coating, delayed-release capsules, or acid-resistant formulations. Standard vegetable cellulose capsules without any enteric treatment may still deliver some active enzyme, especially if taken on an empty stomach, but you are essentially gambling on how much survives the trip through your stomach.
Storage and Shelf Stability
Nattokinase is a protein, and proteins degrade over time when exposed to heat, moisture, and pH extremes. Microencapsulated nattokinase powder has shown strong storage stability across different temperatures and pH conditions, remaining white or light yellow with no off-flavors or degradation after 30 days of storage.8PubMed Central. Microencapsulation of nattokinase from fermentation by spray drying: Optimization, comprehensive score, and stability Well-formulated commercial supplements with proper encapsulation should remain stable for the duration of their labeled shelf life as long as you keep them sealed, dry, and away from excessive heat.
That said, leaving a bottle of nattokinase in a hot car or in direct sunlight for extended periods is a bad idea. Room temperature in a cabinet or pantry is fine. Refrigeration is not necessary for most encapsulated products but will not hurt and can extend potency for products that are approaching their expiration date. If your nattokinase capsules develop an unusual smell, change color significantly, or clump together, those are signs the product has degraded.
Who Should Avoid Nattokinase Entirely
The safety profile of nattokinase in clinical trials is genuinely good. A systematic review and meta-analysis of randomized controlled trials found no notable adverse events among any groups taking nattokinase or placebo.9PubMed Central. Nattokinase Supplementation and Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials But that reassuring finding has a critical caveat: these trials excluded people on anticoagulant therapy. In healthy adults and those with mild cardiovascular risk factors, nattokinase appears well-tolerated. The danger is in specific drug interactions and medical situations.
The most serious documented case involved a patient who replaced warfarin with nattokinase after receiving a mechanical heart valve. After nearly a year of nattokinase use without warfarin, the patient developed a blood clot on the mechanical valve and required emergency repeat surgery. The case report’s authors strongly discouraged using nattokinase as a substitute for warfarin in patients with mechanical valve prostheses.10PubMed Central. Consequence of patient substitution of nattokinase for warfarin after aortic valve replacement with a mechanical prosthesis This case is instructive for two reasons. First, it shows that nattokinase, despite its real fibrinolytic activity, is not potent or reliable enough to replace pharmaceutical anticoagulants in high-stakes situations. Second, it illustrates the kind of decision that can arise when patients discover a “natural” alternative and stop a prescribed medication without medical guidance.
People who should not take nattokinase without explicit medical supervision include:
- Those on anticoagulants: Warfarin, heparin, apixaban, rivaroxaban, and similar drugs all thin the blood. Adding nattokinase on top can increase bleeding risk unpredictably, because the mechanisms stack rather than overlap perfectly.
- Those on antiplatelet drugs: Aspirin and clopidogrel reduce platelet aggregation. Combined with nattokinase’s fibrinolytic effects, this could raise the risk of bleeding events.
- Anyone facing surgery: Because nattokinase can promote clot breakdown, most practitioners recommend stopping it at least two weeks before any scheduled surgical procedure to reduce the risk of excessive bleeding.
- People with bleeding disorders: Conditions like hemophilia or von Willebrand disease already impair clotting. Adding an enzyme that further breaks down clots is a dangerous combination.
- Pregnant or breastfeeding women: There is essentially no safety data for nattokinase in pregnancy or lactation, and given its blood-thinning properties, caution is warranted.
If you are taking any prescription medication that affects blood clotting, talk to your doctor before starting nattokinase. This is not the generic “consult your doctor” hedge that appears on every supplement label. Nattokinase has real, measurable fibrinolytic activity, and combining it with pharmaceutical anticoagulants is a genuine medical risk.
What the Cardiovascular Evidence Actually Shows
The most consistent finding across trials is that nattokinase lowers blood pressure. A randomized, controlled trial found that nattokinase supplementation reduced both systolic and diastolic blood pressure, along with a significant decrease in renin activity compared to the control group.11PubMed. Effects of nattokinase on blood pressure: a randomized, controlled trial The blood-pressure-lowering effect has been replicated in other studies and is one of the more robust findings in the nattokinase literature.
For lipid levels and arterial plaque, the picture is more nuanced. The 26-week trial mentioned earlier found that nattokinase reduced carotid plaque more effectively than a statin drug (about 37% versus 12%), raised HDL cholesterol, and lowered total cholesterol, LDL, and triglycerides, though the statin outperformed nattokinase on raw lipid-lowering numbers.4PubMed Central. A clinical study on the effect of nattokinase on carotid artery atherosclerosis and hyperlipidaemia An interesting wrinkle from that same study: the lipid-lowering effect in the nattokinase group was not correlated with the reduction in plaque size, suggesting that nattokinase may reduce plaque through mechanisms beyond simple cholesterol reduction, possibly through its direct fibrinolytic action on the clot-like components embedded in plaque.
A review of large-scale clinical trials concluded that nattokinase significantly improves lipid profiles and reduces plaque area and arterial wall thickness, with a favorable safety profile overall.12PubMed Central. Research Progress of Nattokinase in Reducing Blood Lipid However, the dose matters. As that large 1,062-participant study showed, 3,600 FU daily was not enough to produce lipid or plaque changes after a full year.3PubMed Central. Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants If you are taking nattokinase primarily for cardiovascular reasons, the evidence suggests you need a meaningful dose, not just a token amount.
Natto the Food Versus Nattokinase the Supplement
Eating natto, the fermented soybean dish, is the original way humans consumed nattokinase, and epidemiological data from Japan has linked regular natto consumption with lower cardiovascular mortality.1MDPI / International Journal of Molecular Sciences. Nattokinase: An Oral Antithrombotic Agent for the Prevention of Cardiovascular Disease A typical serving of natto (about 50 grams, or a small traditional pack) contains nattokinase, but the enzyme content varies depending on the bacterial strain used in fermentation, the fermentation time, and the soybean variety. There is no standardized FU content for a serving of natto the way there is for a supplement capsule.
The advantage of eating natto rather than taking a supplement is that the food comes packaged with vitamin K2 (specifically the MK-7 form), protein, fiber, and other nutrients from the fermented soybeans. The disadvantage is that natto’s taste and texture are polarizing even in Japan, the enzyme content is unpredictable, and for people on warfarin, the high vitamin K2 content can interfere with the drug’s mechanism in the opposite direction from nattokinase itself, making dose management a headache.
Most nattokinase supplements are processed to remove vitamin K2, or at least reduce it substantially. If you are taking nattokinase specifically for its fibrinolytic or cardiovascular effects and you are not a fan of natto’s flavor profile, supplements give you a more controlled and consistent dose. If you enjoy natto and eat it as part of a regular diet, you are getting nattokinase along with other beneficial compounds, but you cannot know exactly how many fibrinolytic units you consumed with dinner.
Emerging Research Beyond Blood Clots
Nattokinase research has branched into some unexpected territory in recent years. One area getting attention is Alzheimer’s disease. Amyloid-beta plaques, the sticky protein aggregates found in the brains of Alzheimer’s patients, turn out to be susceptible to nattokinase degradation. A study using both in vitro experiments and mouse models of Alzheimer’s disease found that nattokinase captured and degraded multiple forms of amyloid-beta peptides. The enzyme was particularly effective against the aggregated forms of these peptides, with suspended oligomers being more easily captured than fibrils in solution, while deposited fibrils recruited more enzyme than deposited oligomers.13Food Science and Human Wellness. Degradation of amyloid β-peptides catalyzed by nattokinase in vivo and in vitro
This is early-stage research and nobody should take nattokinase hoping to prevent or treat Alzheimer’s based on mouse data. But the finding is mechanistically interesting because it suggests nattokinase’s proteolytic activity extends beyond fibrin to other pathological protein aggregates. Whether this has any clinical relevance in humans remains to be seen, and the challenge of getting enough active enzyme across the blood-brain barrier is enormous. Still, it represents a plausible research direction rather than pure speculation, and several groups are actively investigating it.
Other lines of investigation have explored nattokinase’s potential anti-inflammatory effects and its possible role in degrading spike protein, a topic that gained traction online during and after the COVID-19 pandemic. The spike protein research remains very preliminary, with a handful of in vitro studies and no clinical trials establishing benefit in humans. It is worth keeping an eye on, but not worth making supplement decisions based on at this point. The cardiovascular evidence is far more mature and remains the primary reason most people consider nattokinase supplementation.